Clinical trial · Observational
The Impact of Colorectal Cancer Screening on Surgical Outcomes
NCT06416501CI-TRIAL-00077178unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to investigate the pathological characteristics and surgical outcomes of stage III CRC patients detected through screening. Data extracted from the database included the following patient information: age at diagnosis, gender, tumor location, neoadjuvant therapy, surgical procedures, histologic type, differentiation, vascular invasion, perineural invasion, pathological T stage, pathological N stage, and survival outcomes.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Prognosis | — | UNRESOLVED | — |
| Screening | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mode of detection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- screening
- description
- Patients who were detected through any screening test were categorized into the screening group
- interventionNames
- Other: Mode of detection
- label
- nonscreening
- description
- Patients who were detected based on symptoms formed the non-screening group.
Primary outcomes (1)
- measure
- overall survival
- timeFrame
- the duration from the initial treatment to either death from any cause or the last recorded follow-up, whichever came first. Assessed up to 100 months.
- description
- The duration from the initial treatment to either death from any cause or the last recorded follow-up, whichever came first. Assessed up to 100 months.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who underwent radical surgery for CRC, had confirmed stage III CRC through postoperative pathology, had no prior history of cancer before surgery, and had clear cancer detection information.
References
Publications (0)
Data not yet available
No reference posted for this study.